Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1975 1
1981 2
1983 1
1984 1
1985 1
1986 1
1987 1
1988 1
1991 2
1993 1
1995 2
1996 3
1997 10
1998 21
1999 15
2000 12
2001 8
2002 12
2003 14
2004 18
2005 19
2006 21
2007 28
2008 27
2009 31
2010 31
2011 33
2012 52
2013 39
2014 35
2015 36
2016 54
2017 49
2018 41
2019 59
2020 49
2021 70
2022 65
2023 72
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

860 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Golonu
Page 1
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET.
Neijssen J, Cardoso RMF, Chevalier KM, Wiegman L, Valerius T, Anderson GM, Moores SL, Schuurman J, Parren PWHI, Strohl WR, Chiu ML. Neijssen J, et al. J Biol Chem. 2021 Jan-Jun;296:100641. doi: 10.1016/j.jbc.2021.100641. Epub 2021 Apr 8. J Biol Chem. 2021. PMID: 33839159 Free PMC article.
Amivantamab antagonized the hepatocyte growth factor (HGF)-induced signaling by binding to MET Sema domain and thereby blocking HGF beta-chain-Sema engagement. ...
Amivantamab antagonized the hepatocyte growth factor (HGF)-induced signaling by binding to MET Sema domain and thereby blocking HGF b …
Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model.
Niu S, Chen S, Chen X, Ren Q, Yue L, Pan X, Zhao H, Li Z, Chen X. Niu S, et al. Front Endocrinol (Lausanne). 2022 Dec 9;13:1046130. doi: 10.3389/fendo.2022.1046130. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36568109 Free PMC article.
PATIENTS AND METHODS: The 24 C57BL6J mice were randomly divided into three groups (NCD, HFD and Sema) for the assessment of metabolic status, inflammatory factor and oxidative stress marker levels, liver histopathology in mice. ...
PATIENTS AND METHODS: The 24 C57BL6J mice were randomly divided into three groups (NCD, HFD and Sema) for the assessment of metabolic …
GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway.
Xiang J, Qin L, Zhong J, Xia N, Liang Y. Xiang J, et al. Diabetes Metab Syndr Obes. 2023 Aug 15;16:2433-2446. doi: 10.2147/DMSO.S425642. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37602204 Free PMC article.
After establishing an obesity model, mice were further divided into six groups: control group, liraglutide (LIRA) group, semaglutide (SEMA) group, high-fat diet (HFD) group, HFD + LIRA group, HFD + SEMA group, and subcutaneous injection for 4 weeks. ...C2C12 myotube …
After establishing an obesity model, mice were further divided into six groups: control group, liraglutide (LIRA) group, semaglutide (SEM …
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study).
Takahashi Y, Nomoto H, Yokoyama H, Takano Y, Nagai S, Tsuzuki A, Cho KY, Miya A, Kameda H, Takeuchi J, Taneda S, Kurihara Y, Atsumi T, Nakamura A, Miyoshi H; SWITCH-SEMA 1 study group. Takahashi Y, et al. Diabetes Obes Metab. 2023 Jun;25(6):1503-1511. doi: 10.1111/dom.14998. Epub 2023 Feb 28. Diabetes Obes Metab. 2023. PMID: 36722623 Clinical Trial.
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Furusawa S, Nomoto H, Yokoyama H, Suzuki Y, Tsuzuki A, Takahashi K, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Taneda S, Kurihara Y, Nakamura A, Atsumi T; SWITCH-SEMA 2 study group. Furusawa S, et al. Diabetes Obes Metab. 2024 Mar;26(3):961-970. doi: 10.1111/dom.15393. Epub 2023 Dec 11. Diabetes Obes Metab. 2024. PMID: 38073422 Clinical Trial.
NMR spectroscopy of paramagnetic solids.
Ashbrook SE, Jaroniec CP. Ashbrook SE, et al. Solid State Nucl Magn Reson. 2019 Dec;104:101625. doi: 10.1016/j.ssnmr.2019.101625. Epub 2019 Oct 24. Solid State Nucl Magn Reson. 2019. PMID: 31704509 No abstract available.
Motor axon guidance in Drosophila.
Arzan Zarin A, Labrador JP. Arzan Zarin A, et al. Semin Cell Dev Biol. 2019 Jan;85:36-47. doi: 10.1016/j.semcdb.2017.11.013. Epub 2017 Nov 24. Semin Cell Dev Biol. 2019. PMID: 29155221 Review.
Semaphorins and their Signaling Mechanisms.
Alto LT, Terman JR. Alto LT, et al. Methods Mol Biol. 2017;1493:1-25. doi: 10.1007/978-1-4939-6448-2_1. Methods Mol Biol. 2017. PMID: 27787839 Free PMC article. Review.
The more than 20-member semaphorin protein family includes secreted, transmembrane and cell surface-attached proteins with diverse structures, each characterized by a single cysteine-rich extracellular sema domain, the defining feature of the family. Early studies revealed …
The more than 20-member semaphorin protein family includes secreted, transmembrane and cell surface-attached proteins with diverse structure …
The sema domain.
Gherardi E, Love CA, Esnouf RM, Jones EY. Gherardi E, et al. Curr Opin Struct Biol. 2004 Dec;14(6):669-78. doi: 10.1016/j.sbi.2004.10.010. Curr Opin Struct Biol. 2004. PMID: 15582390 Review.
Recently determined crystal structures of two semaphorins (SEMA3A and SEMA4D) and the MET receptor have shown that the sema domain consists of a highly conserved variant form of the seven-blade beta-propeller fold. ...This reflects the considerable plasticity and adaptatio …
Recently determined crystal structures of two semaphorins (SEMA3A and SEMA4D) and the MET receptor have shown that the sema domain co …
The role of the semaphorins in cancer.
Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O. Neufeld G, et al. Cell Adh Migr. 2016 Nov;10(6):652-674. doi: 10.1080/19336918.2016.1197478. Epub 2016 Aug 17. Cell Adh Migr. 2016. PMID: 27533782 Free PMC article. Review.
The semaphorin family contains more then 20 genes divided into 7 subfamilies, all of which contain the signature sema domain. The semaphorins transduce signals by binding to receptors belonging to the neuropilin or plexin families. ...
The semaphorin family contains more then 20 genes divided into 7 subfamilies, all of which contain the signature sema domain. The sem …
860 results